In-hospital Aspirin Dose as a Risk Factor for Hemorrhagic Transformation in Patients Not Treated With Thrombolysis.
João Brainier Clares de AndradeJay P MohrFabricio Oliveira LimaJoao José Freitas de CarvalhoLevi Coelho Maia BarrosOctavio Marques Pontes-NetoGabriel Queiroz de AbreuGisele Sampaio SilvaPublished in: The neurologist (2023)
An increased in-hospital aspirin dose is associated with intracerebral hematoma in patients at a high risk of HT. Stratifying the risk of HT may lead to individualized daily aspirin dose choices. However, clinical trials on this topic are required.
Keyphrases
- low dose
- clinical trial
- cardiovascular events
- antiplatelet therapy
- end stage renal disease
- newly diagnosed
- healthcare
- ejection fraction
- pulmonary embolism
- chronic kidney disease
- cardiovascular disease
- randomized controlled trial
- peritoneal dialysis
- acute coronary syndrome
- anti inflammatory drugs
- percutaneous coronary intervention
- coronary artery disease
- emergency department
- adverse drug
- patient reported
- double blind